All News

Skeletal-related events are frequent complications in patients with cancers. Two abstracts analyzed the use of bone-modifying agents in patients with newly diagnosed multiple myeloma and breast cancer.

According to results from a randomized phase 3 trial presented at the American Society of Clinical Oncology’s recent annual meeting, the addition of isatuximab to pomalidomide and low-dose dexamethasone significantly improvement progression-free survival (PFS) and the overall response rate (ORR) in patients with relapsed or refractory multiple myeloma (RRMM).

Sensory processing difficulties are seen among children with migraine, according to a recently published study, which said that their quality of life is predicted by both headache-related disability and sensory processing difficulties.

The results of the NCI-MATCH precision medicine trial showed that a drug combination designed to target cancers with certain BRAF gene mutations was effective.

According to a recent study presented at the American Thoracic Society International Conference in Dallas, Texas, and simultaneously published in the New England Journal of Medicine, nearly three-fourths of patients with mild, persistent asthma had a low sputum eosinophil levels and did not differ in their response to either mometasone or tiotropium when compared with placebo.

Two posters presented at the 2019 American Society of Clinical Oncology Annual Meeting, held May 31 to June 4, 2019, in Chicago, Illinois, discussed the growing issue of financial toxicity and the costs of care in cancer treatment.

A recent literature review, involving an international multidisciplinary panel of social and healthcare professionals and people living with epidermolysis bullosa (EB), was conducted to create evidence-based guidelines to optimize psychosocial well-being in EB, given that there is no cure or treatment.

There was something for everyone at the American Diabetes Association (ADA) Scientific Sessions, held June 7-11, 2019, in San Francisco, California.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Starting 2020, employees will be able to use health reimbursement arrangements (HRAs) to purchase individual coverage; New York has enacted legislation that ends nonmedical exemptions for school vaccination requirements; the FDA is being sued by Catalyst Pharmaceuticals over its approval of a similar orphan drug.

Earlier this month, the FDA approved the first ever migraine drug, galcanezumab-gnlm (Emgality, Lilly) indicated to treat cluster headaches.

According to a recent study, data collected through a wearable device called the Personal Kinetigraph (PKG) can assist clinicians in recognizing patients with Parkinson disease who may benefit from deep-brain stimulation or other device-assisted therapies.

Results were presented recently at the 79th Scientific Sessions of the American Diabetes Association.

Some states are losing ground in healthcare coverage and most states are being rocked by rising deaths of despair, reports a national scorecard of the nation’s health.

The consensus report was presented at the 79th Scientific Sessions of the American Diabetes Association in San Francisco, California.

A recent study showed that older adults with uncontrolled asthma can benefit from interventions that tailor self-management support to improve various factors that impede asthma control, including those related to psychosocial, health, function, and cognitive barriers.

Diets high in soy are linked with a decreased risk of osteoporotic bone fractures in pre- and perimenopausal survivors of breast cancer.

Both the FDA and the European Medicines Agency (EMA) have accepted applications to review ozanimod, an oral sphingosine 1-phosphate receptor modulator, for the treatment of relapsing forms of multiple sclerosis (MS).

Survival of patients with multiple myeloma has continued to improve as treatments have evolved over time.

CMS has approved Washington state’s proposal for a subscription model to purchase hepatitis C virus (HCV) drugs; the American Medical Association (AMA) voted against a measure that would drop its decades-long stance against single-payer healthcare proposals; Maine has become the eighth state to legalize medically assisted suicide.

In recent years, fatal overdoses from fentanyl have drastically increased across the nation, with the number of deaths nearly doubling each year from 2013 through 2016.

Today marks the second annual International NASH Day created to raise awareness about nonalcoholic steatohepatitis (NASH) and fatty liver disease.

Abstracts presented at the 2019 American Thoracic Society International Conference suggest that participation in clinical trials and 1-on-1 coaching may improve inhaler technique of patients with chronic obstructive pulmonary disease or other respiratory disorders.

The Community Oncology Alliance (COA) has filed its alternative to CMS' Oncology Care Model (OCM) with the Physician-Focused Payment Model Technical Advisory Committee.

The American Medical Association has called for intensified oversight of the pharmacy benefit manager (PBM) industry; the governor of Florida has signed a bill into law that would allow state residents to access cheaper medication through 2 prescription drug importation programs; the Ebola virus has crossed international borders during the second-worst outbreak in history.

While older adults represent a majority of new cancer diagnoses, they are underrepresented in randomized clinical trials.

Geisinger is launching a new study to test if a novel technique can detect flare-ups or exacerbations experienced by patients with chronic obstructive pulmonary disease (COPD) by listening to their voices through their smart phones.

The United States Preventive Services Task Force (USPSTF) has issued 2 recommendation statements including 3 grade A recommendations for the use of pre-exposure prophylaxis (PrEP) for HIV prevention and HIV screening in adults, adolescents, and pregnant women.